7ZIA

Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0634 inhibitor

7ZIA の概要

• エントリーDOI: 10.2210/pdb7zia/pdb
• 分子名称: Deoxycytidine kinase, URIDINE-5'-DIPHOSPHATE, 2-[2-[[2-methyl-5-[6-(4-methylpiperazin-1-yl)sulfonylpyridin-3-yl]phenyl]-propyl-amino]-1,3-thiazol-4-yl]pyrimidine-4,6-diamine, ... (5 entities in total)
• 機能のキーワード: inhibitor, transferase
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 33708.52

構造登録者

Ben-Yaala, K.,Saez-Ayala, M.,Betzi, S.,Rebuffet, E.,Morelli, X. (登録日: 2022-04-07, 公開日: 2023-06-07, 最終更新日: 2024-02-07)

• 主引用文献: Saez-Ayala, M.,Hoffer, L.,Abel, S.,Ben Yaala, K.,Sicard, B.,Andrieu, G.P.,Latiri, M.,Davison, E.K.,Ciufolini, M.A.,Bremond, P.,Rebuffet, E.,Roche, P.,Derviaux, C.,Voisset, E.,Montersino, C.,Castellano, R.,Collette, Y.,Asnafi, V.,Betzi, S.,Dubreuil, P.,Combes, S.,Morelli, X.; From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.; Nat Commun, 14:3079-3079, 2023; PubMed: 37248212; DOI: 10.1038/s41467-023-38668-2

実験手法

X-RAY DIFFRACTION (1.7 Å)